-
Study aim
-
Determination of the effect of 2 different doses of dexmedetomidine intranasal on cardiovascular response to laryngoscopy and endotracheal intubation
-
Design
-
Clinical trial with control group, triple blind, randomized, phase 3 on 90 patients
-
Settings and conduct
-
The study of a triple blind randomized clinical trial with a control group during the years 1401-1400
Will be performed at Al-Zahra Medical Center in Isfahan.
The person collecting the information does not know the study group, nor does the statistician
Does not know the study group
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Age 18-65 years II, I ASA (American Anesthesia Association classification based on patients' physical condition)
without airway anomaly, elective surgery
Inclusion criteria:
History of drug sensitivity, pregnancy, Difficult airway , ECG block, BMI> 30, history of obstruction
Nasopharyngeal ducts
-
Intervention groups
-
Group 1: 1 µg/kg intranasal dexmedetomidine at a concentration of 100 µg/ml in a 1cc syringe after injection of anesthetic drug.
Group 2: 2 µg/kg intranasal dexmedetomidine at a concentration of 100 µg/ml in a 1cc syringe after injection of anesthetic drug.
Group 3: Normal saline with a volume equivalent to groups 1 and 2 intranasally.
-
Main outcome variables
-
Heart rate, systolic blood pressure, diastolic blood pressure, Mean arterial pressure, percentage of oxygen saturation